Alexander Rau | Senior Scientist Protein Engineering
Anaveon

Alexander joined Anaveon in 2022 as a protein engineer, focused on developing the next generation of antibody-cytokine fusion proteins for cancer therapy. He previously worked at a biotech company, focusing on the generation of antibody therapeutics for immuno-oncology. He also has a strong academic background in cancer cell biology and antibody engineering, with the aim of overcoming resistance mechanisms. His main expertise is in developing bispecific antibodies, from screening binders from various sources, designing, cloning, producing and purifying them, to characterizing and testing them in vitro and in vivo.